ANVS
insider transactionsAnnovis Bio, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 2 different insiders made open-market purchases in the last 365 days, totalling $4.5M.
Net shares · 365d
+2.0M
2.0M buy · 0 sell
Net value · 365d
$4.5M
$4.5M in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
19
2.0M buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 365d
-
Buy·P
Director
$142.8K
76.3K sh · $1.87 avg · 3 lots
Own +2%
-
Buy·P
Director
$1.5M
713.8K sh · $2.10
Own +28%
-
Buy·P
Director
$193.8K
45.0K sh · $4.31 avg · 2 lots
Own +2%
-
Buy·P
Director
$159.9K
39.2K sh · $4.08 avg · 4 lots
Own +2%
-
Buy·P
Director
$159.9K
39.2K sh · $4.08 avg · 4 lots
Own +2%
-
Buy·P
Director
$69.9K
20.0K sh · $3.50 avg · 2 lots
Own +1%
-
Buy·P
Director
$31.6K
15.0K sh · $2.11
Own +1%
-
Buy·P
Director
$2.0M
975.6K sh · $2.05
Own +66%
-
Buy·P
President & CEO
$200.0K
97.6K sh · $2.05
Own +9%
-
Exercise·M
Director
$0
7.1K sh
Own New
-
Exercise·M
Director
$1,000
7.1K sh · $0.14
Own +109%
-
Grant·A
Director
$34.4K
15.0K sh · $2.29 avg · 3 lots
Own +1%
-
Grant·A
Director
$48.3K
18.6K sh · $2.59 avg · 4 lots
Own +1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 20, 2026 | Hoffman Michael B | Buy P | 76.3K3 lots | $142.8K |
| Apr 2, 2026 | Hoffman Michael B | Buy P | 713.8K | $1.5M |
| Dec 8, 2025 | Hoffman Michael B | Buy P | 45.0K2 lots | $193.8K |
| Nov 24, 2025 | Hoffman Michael B | Buy P | 39.2K4 lots | $159.9K |
| Nov 24, 2025 | Hoffman Michael B | Buy P | 39.2K4 lots | $159.9K |
| Nov 21, 2025 | Hoffman Michael B | Buy P | 20.0K2 lots | $69.9K |
| Nov 14, 2025 | Hoffman Michael B | Buy P | 15.0K | $31.6K |
| Oct 28, 2025 | Hoffman Michael B | Buy P | 975.6K | $2.0M |
| Oct 28, 2025 | Maccecchini Maria-Luisa KEY | Buy P | 97.6K | $200.0K |
| Sep 10, 2025 | Bruck Claudine | Exercise M | 7.1K | $0 |
| Sep 10, 2025 | Bruck Claudine | Exercise M | 7.1K | $1,000 |
| Aug 29, 2025 | Hoffman Michael B | Grant A | 15.0K3 lots | $34.4K |
| Aug 19, 2025 | Hoffman Michael B | Grant A | 18.6K4 lots | $48.3K |
Buy Sell Non-market (grant · exercise · gift)
About ANVS insider trading
This page tracks insider transactions for Annovis Bio, Inc. (ANVS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.